Ipg Photonics Corp SEC Filings

IPG Photonics (IPGP) insider activity: the company’s SVP, Sales & Strategic Business Development reported open‑market sales on 10/20/2025 totaling 1,678 shares under a Rule 10b5‑1 trading plan adopted on May 28, 2025. Transactions included 350 shares at a weighted average price of $86.03, 1,263 shares at a weighted average price of $87.22, and 65 shares at $87.83.

Following these trades, the reporting person beneficially owned 38,887 shares, held directly.

IPG Photonics (IPGP) reported insider share sales by a director via a pre‑arranged Rule 10b5‑1 trading plan adopted on June 13, 2025. The filing lists multiple open‑market sales on October 13–15, 2025, each recorded with share counts and weighted average prices.

Sales on 10/13/2025 included 1,667 shares at a weighted average price of $82.09 and 29,547 shares at $83.23, among other small blocks. On 10/14/2025, blocks included 1,661 shares at $80.96 and 8,430 shares at $83.22. On 10/15/2025, blocks included 5,315 shares at $84.24 and 7,226 shares at $85.97. After these transactions, the reporting person beneficially owned 6,992,599 shares, held directly.

The plan‑based nature of the trades is noted in the disclosure, and detailed price ranges for each block are available, with the reporting person undertaking to provide per‑price details upon request.

Director Eric Meurice reported option exercise and subsequent share sales in IPG Photonics Corp. (IPGP). On 10/07/2025 he exercised 1,502 director stock options at an exercise price of $87.87 per share, receiving 1,502 shares. Following that, he sold a total of 1,502 shares in two blocks: 674 shares sold at a weighted average price of $89.24 and 828 shares sold at a weighted average price of $90.01, reducing his beneficial ownership to 22,803 shares held directly. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on 03/07/2025. The reporting was signed by an attorney-in-fact on 10/08/2025. The filing shows routine management liquidity from option exercise and plan-driven dispositions, with all transactions disclosed at their execution prices.

IPG Photonics Corp (IPGP) filed a Form 144 notice reporting a proposed sale of 3,002 shares of common stock through Stifel Nicolaus & Company Inc. The aggregate market value of the shares is listed as $268,979 and the proposed approximate sale date is 10/07/2025. The filing shows these shares were acquired on 06/01/2016 by an option exercise and payment at the time of sale is indicated as cash. The issuer's total shares outstanding are reported as 42,219,918, and no sales by the same person were reported in the past three months. The filer represents they are not aware of undisclosed material adverse information.

Insider sale under Rule 10b5-1: An officer and director, Angelo P. Lopresti, sold 1,500 shares of IPG Photonics Corp (IPGP) on 10/06/2025 at a weighted average price of $85.17 per share under a trading plan adopted on 06/13/2025. After the sale, he beneficially owned 62,885 shares directly. The filing states the sales occurred across prices ranging from $85.00 to $85.38 and that detailed per-price quantities are available on request.

This is a routine, pre-planned disposition under a Rule 10b5-1 plan rather than an ad-hoc sale, which provides an affirmative defense against insider trading claims when plan conditions are met. The sale reduced the reporting person’s direct holdings modestly but leaves a substantial remaining stake.

Insider notice to sell 6,000 shares of common stock was filed under Rule 144 for IPG Photonics (IPGP). The filing shows the shares are scheduled for sale on 10/06/2025 through Stifel Nicolaus & Company Inc on Nasdaq, representing 6,000 shares with an $511,045.00 aggregate market value and 42,219,918 shares outstanding.

The securities were acquired as restricted stock units on 03/01/2020 from the issuer, with payment noted as cash. No sales by the same person in the past three months were reported. The filer affirms they are unaware of undisclosed material adverse information and, if applicable, references any Rule 10b5-1 trading plan adoption date in the remarks section.

IPG Photonics amended and restated its Executive Severance Plan, replacing the prior plan and extending coverage generally to executives at the Vice President level and above (the CEO is not a participant). The updated plan clarifies severance triggers for an Involuntary Termination and adjusts treatment of performance-based equity and cash bonuses depending on whether a termination follows a Change in Control. Key changes include prorating performance equity for Tier One executives based on actual performance with an extra twelve months of deemed service, lump-sum cash bonus multiples of 200% for Tier One and 150%/100% for Tier Two/Three in Change in Control scenarios, and a temporary two-year transition window that preserves enhanced benefits for Tier Two and Tier Three executives for qualifying terminations within 24 months of a Change in Control. Four SVPs will be covered as Tier One and had prior employment agreements terminated, continuing as at-will employees under participation agreements that include general releases.

Form 4 summary for IPG Photonics (IPGP): Eugene A. Scherbakov, a director and reported >10% owner, sold shares on 09/23/2025 under a pre-established Rule 10b5-1 trading plan. The Form 4 reports two sale transactions: 1,555 shares at a weighted-average price of $81.54 and 1,145 shares at a weighted-average price of $82.17. Following the sales the filing lists beneficial ownership amounts of 71,275 and 70,130 shares respectively. The filing was signed by an attorney-in-fact on 09/24/2025 and includes commitments to provide detailed per-price execution data upon request.

Form 144 filing by an insider of IPG Photonics (IPGP) discloses a proposed sale of 8,100 shares of common stock through Stifel Nicolaus with an stated aggregate market value of $662,615.00. The filing reports the shares outstanding as 42,219,918 and an approximate sale date of 09/23/2025. The shares to be sold were acquired as restricted stock units: 16,200 RSUs dated 03/01/2020 and 16,200 RSUs dated 03/01/2022, with payment described as cash. The filer certifies there are no undisclosed material adverse facts and indicates no securities of the issuer were sold by the filer in the past three months. The filing is a routine notice of intended sale under Rule 144 and provides broker and acquisition details but no additional narrative or financial results.